Elisabetta Vergani

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Journal for immunotherapy of cancer

Cancers

Experimental dermatology

Genes

Fondazione IRCCS Istituto Nazionale dei Tumori

Università dell'Insubria (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Biologist, PhD :: Oncologia Sperimentale e Medicina Molecolare

Education History

Università dell'Insubria - Jun 18 2008

Italy

MSC

Publications

Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for immunotherapy of cancer 12 (1) (2024)
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for immunotherapy of cancer 12 (1) (2024)
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for immunotherapy of cancer 12 (1) (2024)
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for immunotherapy of cancer 12 (1) (2024)
Viviana Vallacchi, Elisabetta Vergani, Mara Cossa, Chiara Gargiuli, Adele Busico, Andrea Devecchi, Matteo Dugo, Laura Bergamaschi, Loris De Cecco, Stefano Cavalieri, Barbara Valeri, Elena Tamborini, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Marialuisa Sensi, Licia Rivoltini, Lorenza Di Guardo, Monica Rodolfo
Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for immunotherapy of cancer 12 (1) (2024)
Veronica Huber, Viviana Vallacchi, Elena Daveri, Elisabetta Vergani
3D models for melanoma γδ T cell-based immunotherapy. Clinical and translational medicine 12 (6) (2022)
Elisa Orlandi, Elisa De Tomi, Rachele Campagnari, Francesca Belpinati, Monica Rodolfo, Elisabetta Vergani, Giovanni Malerba, Macarena Gomez-Lira, Marta Menegazzi, Maria Grazia Romanelli
Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation. Current issues in molecular biology 44 (10) (2022)
Giovanni Paolino, Veronica Huber, Serena Camerini, Marialuisa Casella, Alberto Boffi, Lucia Bertuccini, Francesca Iosi, Elisa Moliterni, Serena Cecchetti, Irene Ruspantini, Flavia Chiarotti, Elisabetta Vergani, Luca Lalli, Carla Raggi, Antonella Di Biase, Stefano Calvieri, Santo Raffaele Mercuri, Luana Lugini, Cristina Federici
The Fatty Acid and Protein Profiles of Circulating CD81-Positive Small Extracellular Vesicles Are Associated with Disease Stage in Melanoma Patients. Cancers 13 (16) (2021)
Serena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, Matteo Dugo, Cristina Corno, Elisabetta Corna, Stella Tinelli, Simona Frigerio, Emilio Ciusani, Monica Rodolfo, Paola Perego, Laura Gatti
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations. Cancers 13 (9) (2021)
Elisabetta Vergani, Simona Frigerio, Matteo Dugo, Andrea Devecchi, Erika Feltrin, Loris De Cecco, Viviana Vallacchi, Mara Cossa, Lorenza Di Guardo, Siranoush Manoukian, Bernard Peissel, Andrea C Ferrari, Gianfrancesco Gallino, Andrea Maurichi, Licia Rivoltini, Marialuisa Sensi, Monica Rodolfo
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients. Genes 12 (9) (2021)
Francesca Belpinati, Giovanni Malerba, Melissa Dal Toè, Laura Ceccuzzi, Monica Rodolfo, Albino Poli, Alberto Turco, Elisabetta Vergani, Antonella Sangalli, Macarena Gomez-Lira
Enhancer of zeste 2 polycomb repressive complex 2 subunit polymorphisms in melanoma skin cancer risk. Experimental dermatology 29 (10) (2020)

Elisabetta Vergani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisabetta Vergani